Gedeon Richter PLC
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RGEDF research report →
Companywww.gedeonrichter.com
Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. It operates through the following segments: Pharmaceuticals, Wholesale & Retail, and Others. The Pharmaceutical segment engages in research and development, manufacturing, sales and marketing of pharmaceutical products.
- CEO
- Gabor Orban
- IPO
- 2013
- Employees
- 10,943
- HQ
- Budapest, HU
Price Chart
Valuation
- Market Cap
- $7.15B
- P/E
- 9.71
- P/S
- 2.42
- P/B
- 1.53
- EV/EBITDA
- 5.72
- Div Yield
- 3.54%
Profitability
- Gross Margin
- 67.55%
- Op Margin
- 33.69%
- Net Margin
- 24.80%
- ROE
- 16.73%
- ROIC
- 16.00%
Growth & Income
- Revenue
- $923.40B · 7.68%
- Net Income
- $230.94B · -3.47%
- EPS
- $1263.79 · -3.31%
- Op Income
- $321.78B
- FCF YoY
- 15.12%
Performance & Tape
- 52W High
- $45.28
- 52W Low
- $27.17
- 50D MA
- $37.66
- 200D MA
- $31.85
- Beta
- 0.33
- Avg Volume
- 577
Get TickerSpark's AI analysis on RGEDF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our RGEDF Coverage
We haven't published any research on RGEDF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RGEDF Report →